Crossmark Global Holdings Inc. Sells 4,255 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Crossmark Global Holdings Inc. reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.6% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,392 shares of the medical instruments supplier’s stock after selling 4,255 shares during the period. Crossmark Global Holdings Inc.’s holdings in DENTSPLY SIRONA were worth $309,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Nuance Investments LLC boosted its holdings in shares of DENTSPLY SIRONA by 30.4% in the 4th quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares in the last quarter. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 1.2% in the 4th quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock valued at $348,314,000 after purchasing an additional 120,508 shares during the last quarter. Wellington Management Group LLP raised its position in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after purchasing an additional 1,419,503 shares during the last quarter. Generation Investment Management LLP raised its position in shares of DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after purchasing an additional 1,998,012 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in shares of DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after purchasing an additional 343,915 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $25.00 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The firm has a market cap of $5.19 billion, a price-to-earnings ratio of -56.82, a price-to-earnings-growth ratio of 1.22 and a beta of 1.01. The company has a 50 day moving average price of $25.31 and a 200-day moving average price of $28.52. DENTSPLY SIRONA Inc. has a 1-year low of $23.58 and a 1-year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. DENTSPLY SIRONA’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the firm earned $0.51 earnings per share. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.56%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research analyst reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Finally, Stifel Nicolaus reduced their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $33.44.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.